Advances in clinical assessment and decision-making of intraductal papillary mucinous neoplasm in pancreas
10.3760/cma.j.cn113884-20221002-00379
- VernacularTitle:胰腺导管内乳头状粘液瘤临床评估及诊疗决策的研究进展
- Author:
Yanwei WANG
1
;
Chenghao CUI
;
Yurong LIANG
Author Information
1. 解放军医学院，北京 100853
- Keywords:
Pancreatic intraductal neoplasms;
Clinical evaluation;
Decision-making
- From:
Chinese Journal of Hepatobiliary Surgery
2023;29(4):316-320
- CountryChina
- Language:Chinese
-
Abstract:
Intraductal papillary mucinous neoplasm (IPMN) is one of the precancerous lesions of the pancreas. Currently there is controversial over the management and follow-up strategy of IPMN, including the timing of surgery. The core problem lies in the accurate preoperative assessment of the nature of the lesions and the risk of malignant transformation. Cumulation of high-quality evidence and development of efficient evaluation methods are vital for the establishment of standardized decision-making system and the improvement of clinical benefits to patients. This review aims to summarize the consensus and controversies on surgical evaluation standards in the latest guidelines and representative literatures, and to look forward to the development direction of IPMN diagnosis and treatment decisions in combination with the progress of related evaluation techniques.
